Innocutis launches buccal tablet for cold sores; New software tracks nanoparticles;

> Innocutis announced July 21 the launch of a 50 mg buccal tablet for cold sores. Release

> The FDA issued a warning about pure caffeine bulk bags marketed directly to consumers over the internet. A teaspoon of pure caffeine is about equivalent to 25 cups of coffee, and can easily cause an overdose, leading to dangerously erratic heartbeat, seizures and even death. Notice

> Malvern Instruments just launched NTA 3.0, an upgraded version of its software to track nanoparticles. More

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.